Annolyse
BriefingsCompaniesInsightsPrinciplesCompareWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology
  • Developers

© 2026 Annolyse. Analytical briefings for NZX company announcements.

Table of contents

  1. What changed
  2. What matters
  3. Expectations
  4. Quality of result
  5. Unresolved
  6. Key metrics
  7. Analytical metrics
  8. Metric context
  9. Reference material
←Back to briefings
Iperion (IPR) / FY24

FY24 loss widened 190% to NZ$812.3m, halving equity in a still pre-revenue year

Operating cash outflows jumped 78% to NZ$724.9m, cutting closing cash to NZ$168.6m while the business remains pre-commercial.

Release date
29 May 2024
Published
22 April 2026
Table of Contents⌄
  1. What changed
  2. What matters
  3. Expectations
  4. Quality of result
  5. Unresolved
  6. Key metrics
  7. Analytical metrics
  8. Metric context
  9. Reference material

What changed

  • The headline "Revenue from continuing operations" line printed NZ$0 in both years. The NZ$26.1m booked in FY23 (absent in FY24) relates to interest income, not operating revenue, so the -100% move is a treasury effect of a smaller cash base rather than a demand signal.
  • Loss before tax and net loss both widened to -NZ$812.3m from -NZ$280.1m, a 190% deterioration. No tax charge was recognised in either year, so PBT and NPAT move 1:1.
  • Net cash outflow from operating activities grew to -NZ$724.9m from -NZ$407.8m (-77.8%). With NZ$9.3m of intangible capex, pre-lease free cash flow was approximately -NZ$734.2m.
  • Cash fell 55.9% to NZ$168.6m from NZ$382.1m. Total assets halved to NZ$898.5m (from NZ$1.7b) and total equity to NZ$814.1m (from NZ$1.6b), with the equity fall (-NZ$812.3m) almost exactly matching the statutory loss.
  • No dividend was declared, consistent with the prior year.

What matters

  • Operating burn has accelerated materially while there is still no commercial revenue. Operating outflows rose NZ$317.1m year-on-year with no offsetting revenue line, meaning the step-up is pure cost, not a scaling-cost-before-scaling-revenue story.
  • Balance sheet has contracted faster than cash. Equity halved and total assets fell NZ$839.2m, versus a NZ$213.5m cash drop, implying roughly NZ$520m of non-cash asset declines and/or investment realisations funding a portion of the burn. The gap between the NZ$812.3m loss and the NZ$724.9m operating outflow (~NZ$87.3m) also points to sizeable non-cash charges embedded in the loss.
  • Runway has compressed. Closing cash of NZ$168.6m against an FY24 operating outflow of NZ$724.9m implies materially less than a year of cover at the current burn rate, even before capex, unless burn moderates or the company raises capital.

Expectations

No quantitative targets or forward-work figures were disclosed. The interim commentary pointed only to "strong balance sheet" language and progress on manufacturing/product certifications and sales and marketing ahead of commercial production. The FY24 result does not support that balance-sheet framing as strongly as the HY24 statement did: cash has more than halved and equity is down 49.9%. The half-year shape (HY24 NPAT was 57% of the full year; HY24 OCF was 51%) shows the second half was only modestly smaller than the first, so there is no evidence of a decelerating burn trajectory within the year.

Quality of result

The result is almost entirely burn-driven rather than timing- or working-capital-driven. With zero operating revenue, there is no margin line to assess, no receivables cycle to distort reporting, and no non-recurring items disclosed. Cash conversion cannot be measured against EBITDA (current EBITDA is not disclosed and prior EBITDA was already negative), but on a level basis the operating outflow deteriorated by NZ$317.1m year-on-year, and FCF at -NZ$734.2m is about 90% of the statutory NPAT — meaning the loss is largely cash. The NZ$87.3m residual between NPAT and OCF is a non-cash component that the release excerpts do not reconcile.

Unresolved

  • What drove the NZ$532.2m step-up in losses: R&D phase costs, asset impairments, fair-value movements on investments, or a mix? The release excerpts do not provide a line-item bridge.
  • Why did total assets fall NZ$839.2m while cash fell only NZ$213.5m — i.e., what non-cash assets were written down or realised, and at what recovery?
  • Given NZ$168.6m of closing cash and an FY24 burn near NZ$725m, what is the funding plan for FY25 and the expected timing of first commercial revenue tied to the referenced manufacturing/product certifications?
  • Why was interest income of NZ$26.1m in FY23 effectively absent in FY24 despite a still-substantial average cash balance through the year?
  • Are there any committed facilities, contingent liabilities, or covenant constraints behind the NZ$84.4m of total liabilities?

This briefing cannot assess the technology, certification status, order book, or probability of commercialisation, because the supplied release excerpts contain no product, pipeline, or forward-work detail.

Key metrics

← Swipe to view more
Key metrics table for Iperion FY24
Metric FY24 FY23 Change
Revenue $0m $26.1m -100.0% ↓
EBITDA — −$280.1m —
Net profit after tax −$812.3m −$280.1m -190.0% ↓
Net cash inflow from operating activities −$724.9m −$407.8m -77.8% ↓
Profit before tax −$812.3m −$280.1m -190.0% ↓
Cash and cash equivalents $168.6m $382.1m -55.9% ↓
Total assets $898.5m $1.7b -48.3% ↓

Analytical metrics

← Swipe to view more
Analytical metrics table for Iperion FY24
Metric FY24 FY23 Context
FCF pre-lease −$734.2m — —
FCF post-lease −$734.2m — —
FCF / NPAT 90.4% — complementary conversion metric
Capex $9.3m — —
Payout ratio vs NPAT 0.0% — —
Payout ratio vs FCF pre-lease 0.0% — covered
ROE (annualised) -66.6% — —
HY24 share of FY24 NPAT 57.0% — Other half was 43.0%
Profit from continuing operations −$812.3m −$280.1m −$532.2m

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Source-backed analysis from the filing set attached to this briefing.

Metric context

Trajectory before this result

A compact view of the company's recent revenue and margin path, derived from the same metrics history that powers the company page.

IPR revenue trajectory

Revenue context before the current result.

← Swipe to view more
IPR revenue trajectory preview table
PeriodIPR
FY24$0m
HY24$20.8m
FY23$26.1m
HY23$10.3m
FY22$11.3m
HY22$4m

IPR EBITDA margin

Earnings margin across covered periods.

← Swipe to view more
IPR EBITDA margin preview table
PeriodIPR
FY24n/a
HY24n/a
FY23-1.1%
HY23-1.3%
FY22n/a
HY22n/a

Appendix

Reference material

Company materials considered in this briefing.

Current period

IPR 2024 Preliminary Full Year Result (Unaudited)

FY24 / financial report↗

Prior comparable period

Preliminary Full Year Announcement 31 March 2023

FY23 / financial report↗

Interim context

IPR 1H24 Interim Report

HY24 / financial report↗

IPR 1H24 NZX Results Template

HY24 / results announcement↗

Related insight

See how dividend coverage compares across covered companies

→

See how earnings quality compares across covered companies

→

Email updates

Want briefings like this for the next reporting season?

Get the next Annolyse briefing by email when it is published.

IPR revenue trajectory

Revenue context before the current result.

IPR EBITDA margin

Earnings margin across covered periods.